Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Reactivity and properties of bis(chlorodifluoroacetyl) peroxide generated in situ from chlorodifluoroacetic anhydride for chlorodifluoromethylation reactions.

Kawamura S, Henderson CJ, Aoki Y, Sekine D, Kobayashi S, Sodeoka M.

Chem Commun (Camb). 2018 Sep 21. doi: 10.1039/c8cc05905e. [Epub ahead of print]

PMID:
30238112
2.

Functional plasticity in vertebrate scavenger assemblages in the presence of introduced competitors.

Bingham EL, Gilby BL, Olds AD, Weston MA, Connolly RM, Henderson CJ, Maslo B, Peterson CF, Voss CM, Schlacher TA.

Oecologia. 2018 Oct;188(2):583-593. doi: 10.1007/s00442-018-4217-0. Epub 2018 Jul 6.

PMID:
29980845
3.

Suppurative cribriform ulcers in one leg.

Chan L, Henderson CJ, Weller PA, Tong PL.

Int J Dermatol. 2018 May 11. doi: 10.1111/ijd.14024. [Epub ahead of print] No abstract available.

PMID:
29749610
4.

Identification of Novel Pathways of Osimertinib Disposition and Potential Implications for the Outcome of Lung Cancer Therapy.

MacLeod AK, Lin, Huang JT, McLaughlin LA, Henderson CJ, Wolf CR.

Clin Cancer Res. 2018 May 1;24(9):2138-2147. doi: 10.1158/1078-0432.CCR-17-3555. Epub 2018 Feb 6.

PMID:
29437786
5.

Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice.

Reed L, Mrizova I, Barta F, Indra R, Moserova M, Kopka K, Schmeiser HH, Wolf CR, Henderson CJ, Stiborova M, Phillips DH, Arlt VM.

Arch Toxicol. 2018 Apr;92(4):1625-1638. doi: 10.1007/s00204-018-2162-7. Epub 2018 Jan 24.

6.

Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function.

Pandey AV, Henderson CJ, Ishii Y, Kranendonk M, Backes WL, Zanger UM.

Front Pharmacol. 2017 Nov 27;8:881. doi: 10.3389/fphar.2017.00881. eCollection 2017. No abstract available.

7.

Measuring in vivo responses to endogenous and exogenous oxidative stress using a novel haem oxygenase 1 reporter mouse.

McMahon M, Ding S, Acosta-Jimenez LP, Frangova TG, Henderson CJ, Wolf CR.

J Physiol. 2018 Jan 1;596(1):105-127. doi: 10.1113/JP274915. Epub 2017 Nov 23.

8.

Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic Metabolites.

Lin, Kostov R, Huang JT, Henderson CJ, Wolf CR.

J Pharmacol Exp Ther. 2017 Oct;363(1):12-19. doi: 10.1124/jpet.117.243246.

9.

Xenobiotic CAR Activators Induce Dlk1-Dio3 Locus Noncoding RNA Expression in Mouse Liver.

Pouché L, Vitobello A, Römer M, Glogovac M, MacLeod AK, Ellinger-Ziegelbauer H, Westphal M, Dubost V, Stiehl DP, Dumotier B, Fekete A, Moulin P, Zell A, Schwarz M, Moreno R, Huang JTJ, Elcombe CR, Henderson CJ, Roland Wolf C, Moggs JG, Terranova R.

Toxicol Sci. 2017 Aug 1;158(2):367-378. doi: 10.1093/toxsci/kfx104.

PMID:
28541575
10.

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.

MacLeod AK, Acosta-Jimenez L, Coates PJ, McMahon M, Carey FA, Honda T, Hayes JD, Henderson CJ, Wolf CR.

Br J Cancer. 2017 Aug 22;117(5):e1. doi: 10.1038/bjc.2017.80. Epub 2017 Mar 21.

11.

Feedback control of AHR signalling regulates intestinal immunity.

Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, Stockinger B.

Nature. 2017 Feb 9;542(7640):242-245. doi: 10.1038/nature21080. Epub 2017 Feb 1.

12.

MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response.

Ho V, Chung L, Revoltar M, Lim SH, Tut TG, Abubakar A, Henderson CJ, Chua W, Ng W, Lee M, De Souza P, Morgan M, Lee CS, Shin JS.

PLoS One. 2016 Dec 8;11(12):e0167675. doi: 10.1371/journal.pone.0167675. eCollection 2016.

13.

Aryl hydrocarbon receptor is required for optimal B-cell proliferation.

Villa M, Gialitakis M, Tolaini M, Ahlfors H, Henderson CJ, Wolf CR, Brink R, Stockinger B.

EMBO J. 2017 Jan 4;36(1):116-128. doi: 10.15252/embj.201695027. Epub 2016 Nov 14.

14.

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.

MacLeod AK, Acosta-Jimenez L, Coates PJ, McMahon M, Carey FA, Honda T, Henderson CJ, Wolf CR.

Br J Cancer. 2016 Dec 6;115(12):1530-1539. doi: 10.1038/bjc.2016.363. Epub 2016 Nov 8. Erratum in: Br J Cancer. 2017 Aug 22;117(5):e1.

15.

Optimising Land-Sea Management for Inshore Coral Reefs.

Gilby BL, Olds AD, Connolly RM, Stevens T, Henderson CJ, Maxwell PS, Tibbetts IR, Schoeman DS, Rissik D, Schlacher TA.

PLoS One. 2016 Oct 20;11(10):e0164934. doi: 10.1371/journal.pone.0164934. eCollection 2016.

16.

Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with Antidepressants.

MacLeod AK, McLaughlin LA, Henderson CJ, Wolf CR.

Drug Metab Dispos. 2017 Jan;45(1):17-22. Epub 2016 Oct 18.

17.

Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.

Takahashi S, Fukami T, Masuo Y, Brocker CN, Xie C, Krausz KW, Wolf CR, Henderson CJ, Gonzalez FJ.

J Lipid Res. 2016 Dec;57(12):2130-2137. Epub 2016 Sep 16.

18.

Ulnar-Sided Wrist Pain in the Athlete.

Henderson CJ, Kobayashi KM.

Orthop Clin North Am. 2016 Oct;47(4):789-98. doi: 10.1016/j.ocl.2016.05.017. Review.

PMID:
27637665
19.

Olaparib, Monotherapy or with Ionizing Radiation, Exacerbates DNA Damage in Normal Tissues: Insights from a New p21 Reporter Mouse.

McMahon M, Frangova TG, Henderson CJ, Wolf CR.

Mol Cancer Res. 2016 Dec;14(12):1195-1203. Epub 2016 Sep 7.

20.

Quantifying the influence of small omnivorous fishes on seagrass epiphyte load.

Gilby BL, Henderson CJ, Tibbetts IR, Burfeind DD.

J Fish Biol. 2016 Sep;89(3):1905-12. doi: 10.1111/jfb.13096. Epub 2016 Jul 26.

PMID:
27456225
21.

Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π.

McMillan DH, van der Velden JL, Lahue KG, Qian X, Schneider RW, Iberg MS, Nolin JD, Abdalla S, Casey DT, Tew KD, Townsend DM, Henderson CJ, Wolf CR, Butnor KJ, Taatjes DJ, Budd RC, Irvin CG, van der Vliet A, Flemer S, Anathy V, Janssen-Heininger YM.

JCI Insight. 2016 Jun 2;1(8). pii: e85717.

22.

An evaluation of Minor Groove Binders as anti-lung cancer therapeutics.

Scott FJ, Puig-Sellart M, Khalaf AI, Henderson CJ, Westrop G, Watson DG, Carter K, Grant MH, Suckling CJ.

Bioorg Med Chem Lett. 2016 Aug 1;26(15):3478-86. doi: 10.1016/j.bmcl.2016.06.040. Epub 2016 Jun 16.

PMID:
27349332
23.

Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.

Nelson LJ, Morgan K, Treskes P, Samuel K, Henderson CJ, LeBled C, Homer N, Grant MH, Hayes PC, Plevris JN.

Basic Clin Pharmacol Toxicol. 2017 Jan;120(1):30-37. doi: 10.1111/bcpt.12631. Epub 2016 Jul 15.

24.

Automatic effects of illness schema activation on behavioral manifestations of illness.

Orbell S, Henderson CJ.

Health Psychol. 2016 Oct;35(10):1144-53. doi: 10.1037/hea0000375. Epub 2016 Jun 2.

PMID:
27253428
25.

Assessing the suitability of a non-lethal biopsy punch for sampling fish muscle tissue.

Henderson CJ, Stevens TF, Lee SY.

Fish Physiol Biochem. 2016 Dec;42(6):1521-1526. Epub 2016 May 13.

PMID:
27178186
26.

The early bird and the worm: a case of cercarial dermatitis.

Frew JW, Henderson CJ, McCrossin ID.

Med J Aust. 2016 Feb 15;204(3):122-3.e1. No abstract available.

PMID:
26866553
27.

The Role of Protein-Protein and Protein-Membrane Interactions on P450 Function.

Scott EE, Wolf CR, Otyepka M, Humphreys SC, Reed JR, Henderson CJ, McLaughlin LA, Paloncýová M, Navrátilová V, Berka K, Anzenbacher P, Dahal UP, Barnaba C, Brozik JA, Jones JP, Estrada DF, Laurence JS, Park JW, Backes WL.

Drug Metab Dispos. 2016 Apr;44(4):576-90. doi: 10.1124/dmd.115.068569. Epub 2016 Feb 5. Review.

28.

Model Systems for Understanding Mechanisms of Nongenotoxic Carcinogenesis: Response.

Braeuning A, Henderson CJ, Wolf CR, Schwarz M.

Toxicol Sci. 2015 Oct;147(2):299-300. No abstract available.

PMID:
26668886
29.

Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models.

MacLeod AK, McLaughlin LA, Henderson CJ, Wolf CR.

Cancer Res. 2015 Nov 1;75(21):4573-81. doi: 10.1158/0008-5472.CAN-15-1454. Epub 2015 Sep 11.

30.

Altered protein S-glutathionylation identifies a potential mechanism of resistance to acetaminophen-induced hepatotoxicity.

McGarry DJ, Chakravarty P, Wolf CR, Henderson CJ.

J Pharmacol Exp Ther. 2015 Nov;355(2):137-44. doi: 10.1124/jpet.115.227389. Epub 2015 Aug 26.

31.

Defining Human Pathways of Drug Metabolism In Vivo through the Development of a Multiple Humanized Mouse Model.

Scheer N, Kapelyukh Y, Rode A, Oswald S, Busch D, McLaughlin LA, Lin D, Henderson CJ, Wolf CR.

Drug Metab Dispos. 2015 Nov;43(11):1679-90. doi: 10.1124/dmd.115.065656. Epub 2015 Aug 11.

32.

Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action.

Kostov RV, Knatko EV, McLaughlin LA, Henderson CJ, Zheng S, Huang JT, Honda T, Dinkova-Kostova AT.

Biochem Biophys Res Commun. 2015 Sep 25;465(3):402-7. doi: 10.1016/j.bbrc.2015.08.016. Epub 2015 Aug 8.

33.

Illness Schema Activation and the Effects of Illness Seasonality on Accessibility of Implicit Illness-Related Information.

Orbell S, Henderson CJ, Hagger MS.

Ann Behav Med. 2015 Dec;49(6):918-23. doi: 10.1007/s12160-015-9719-y. No abstract available.

PMID:
26123981
34.

Proteome-wide identification and quantification of S-glutathionylation targets in mouse liver.

McGarry DJ, Chen W, Chakravarty P, Lamont DL, Wolf CR, Henderson CJ.

Biochem J. 2015 Jul 1;469(1):25-32. doi: 10.1042/BJ20141256. Epub 2015 Apr 20.

PMID:
25891661
35.

Evidence that the capacity of nongenotoxic carcinogens to induce oxidative stress is subject to marked variability.

Henderson CJ, Cameron AR, Chatham L, Stanley LA, Wolf CR.

Toxicol Sci. 2015 May;145(1):138-48. doi: 10.1093/toxsci/kfv039. Epub 2015 Feb 17.

36.

Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo.

Henderson CJ, McLaughlin LA, Scheer N, Stanley LA, Wolf CR.

Mol Pharmacol. 2015 Apr;87(4):733-9. doi: 10.1124/mol.114.097394. Epub 2015 Feb 5.

37.

Value of an Additional Review for Eosinophil Quantification in Esophageal Biopsies.

Stucke EM, Clarridge KE, Collins MH, Henderson CJ, Martin LJ, Rothenberg ME.

J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):65-8. doi: 10.1097/MPG.0000000000000740.

38.

An enhanced in vivo stable isotope labeling by amino acids in cell culture (SILAC) model for quantification of drug metabolism enzymes.

MacLeod AK, Fallon PG, Sharp S, Henderson CJ, Wolf CR, Huang JT.

Mol Cell Proteomics. 2015 Mar;14(3):750-60. doi: 10.1074/mcp.M114.043661. Epub 2015 Jan 5.

39.

HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents.

McMahon M, Campbell KH, MacLeod AK, McLaughlin LA, Henderson CJ, Wolf CR.

PLoS One. 2014 Nov 26;9(11):e114055. doi: 10.1371/journal.pone.0114055. eCollection 2014.

40.

Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability.

Henderson CJ, McLaughlin LA, Osuna-Cabello M, Taylor M, Gilbert I, McLaren AW, Wolf CR.

Biochem J. 2015 Feb 1;465(3):479-88. doi: 10.1042/BJ20140582.

PMID:
25377919
41.

In vivo regulation of human glutathione transferase GSTP by chemopreventive agents.

Henderson CJ, McLaren AW, Wolf CR.

Cancer Res. 2014 Aug 15;74(16):4378-87. doi: 10.1158/0008-5472.CAN-14-0792. Epub 2014 Jun 16.

42.

Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR.

Braeuning A, Gavrilov A, Brown S, Wolf CR, Henderson CJ, Schwarz M.

Toxicol Sci. 2014 Aug 1;140(2):259-70. doi: 10.1093/toxsci/kfu099. Epub 2014 May 25.

PMID:
24863967
43.

Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors.

Luisier R, Lempiäinen H, Scherbichler N, Braeuning A, Geissler M, Dubost V, Müller A, Scheer N, Chibout SD, Hara H, Picard F, Theil D, Couttet P, Vitobello A, Grenet O, Grasl-Kraupp B, Ellinger-Ziegelbauer H, Thomson JP, Meehan RR, Elcombe CR, Henderson CJ, Wolf CR, Schwarz M, Moulin P, Terranova R, Moggs JG.

Toxicol Sci. 2014 Jun;139(2):501-11. doi: 10.1093/toxsci/kfu038. Epub 2014 Apr 1.

PMID:
24690595
44.

Deletion of 30 murine cytochrome p450 genes results in viable mice with compromised drug metabolism.

Scheer N, McLaughlin LA, Rode A, Macleod AK, Henderson CJ, Wolf CR.

Drug Metab Dispos. 2014 Jun;42(6):1022-30. doi: 10.1124/dmd.114.057885. Epub 2014 Mar 26.

45.

Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.

Stiborová M, Moserová M, Černá V, Indra R, Dračínský M, Šulc M, Henderson CJ, Wolf CR, Schmeiser HH, Phillips DH, Frei E, Arlt VM.

Toxicology. 2014 Apr 6;318:1-12. doi: 10.1016/j.tox.2014.02.002. Epub 2014 Feb 14.

PMID:
24530354
46.

Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.

Henderson CJ, Ngeow J, Collins MH, Martin LJ, Putnam PE, Abonia JP, Marsolo K, Eng C, Rothenberg ME.

J Pediatr Gastroenterol Nutr. 2014 May;58(5):553-60. doi: 10.1097/MPG.0000000000000253.

47.

A targeted in vivo SILAC approach for quantification of drug metabolism enzymes: regulation by the constitutive androstane receptor.

Macleod AK, Zang T, Riches Z, Henderson CJ, Wolf CR, Huang JT.

J Proteome Res. 2014 Feb 7;13(2):866-74. doi: 10.1021/pr400897t. Epub 2013 Dec 12.

48.

Pyrethroid activity-based probes for profiling cytochrome P450 activities associated with insecticide interactions.

Ismail HM, O'Neill PM, Hong DW, Finn RD, Henderson CJ, Wright AT, Cravatt BF, Hemingway J, Paine MJ.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19766-71. doi: 10.1073/pnas.1320185110. Epub 2013 Nov 18.

49.

A role for cytochrome b5 in the In vivo disposition of anticancer and cytochrome P450 probe drugs in mice.

Henderson CJ, McLaughlin LA, Finn RD, Ronseaux S, Kapelyukh Y, Wolf CR.

Drug Metab Dispos. 2014 Jan;42(1):70-7. doi: 10.1124/dmd.113.055277. Epub 2013 Oct 10.

50.

Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition.

Ubesie AC, Kocoshis SA, Mezoff AG, Henderson CJ, Helmrath MA, Cole CR.

J Pediatr. 2013 Dec;163(6):1692-6. doi: 10.1016/j.jpeds.2013.07.015. Epub 2013 Aug 24.

Supplemental Content

Loading ...
Support Center